Getein Biotech, Inc (603387.SS)

9.04 +0.04 (+0.44%) At close: 03:00PM CST

Getein Biotech, Inc

No.9 Bofu Road
Intelligent Manufacturing Industrial Park Jiangbei New District
Nanjing 211505
China
86 25 6856 8588
https://www.getein.com.cn

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 2,508

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Gang Zhu	Deputy GM & Director	N/A	N/A	1986

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection of cardiac troponin I, chemiluminescence, biochemical detection, molecular detection, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, thrombosis and hemostasis, and other technical fields, covering cardiovascular, inflammation, kidney, thyroid function, hormone, glucose metabolism, tumor, blood cells, blood coagulation, and other detection fields. Its product applications include laboratory departments of medical institutions, emergency rooms, health examination center, community clinic, family personal health management, etc. The company was founded in 2002 and is headquartered in Nanjing, China.

Corporate governance

Getein Biotech, Inc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.